147 related articles for article (PubMed ID: 37810691)
1. Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities.
Froimowitz M; Taboada R; Poulos ZJ; Rainone DJ; Imler GH; Gardner EL; Kelley CJ
ACS Omega; 2023 Oct; 8(39):35738-35745. PubMed ID: 37810691
[TBL] [Abstract][Full Text] [Related]
2. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
[TBL] [Abstract][Full Text] [Related]
3. Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT.
Froimowitz M; Patrick KS; Cody V
Pharm Res; 1995 Oct; 12(10):1430-4. PubMed ID: 8584475
[TBL] [Abstract][Full Text] [Related]
4. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
Heal DJ; Pierce DM
CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.
Aoyama T; Kotaki H; Sawada Y; Iga T
Pharm Res; 1994 Mar; 11(3):407-11. PubMed ID: 8008708
[TBL] [Abstract][Full Text] [Related]
7. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
Froimowitz M; Gu Y; Dakin LA; Nagafuji PM; Kelley CJ; Parrish D; Deschamps JR; Janowsky A
J Med Chem; 2007 Jan; 50(2):219-32. PubMed ID: 17228864
[TBL] [Abstract][Full Text] [Related]
8. Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.
Heal DJ; Gosden J; Smith SL
Neuropharmacology; 2014 Dec; 87():19-40. PubMed ID: 24953830
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse.
Sparago M; Wlos J; Yuan J; Hatzidimitriou G; Tolliver J; Dal Cason TA; Katz J; Ricaurte G
J Pharmacol Exp Ther; 1996 Nov; 279(2):1043-52. PubMed ID: 8930215
[TBL] [Abstract][Full Text] [Related]
11. Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter.
Mayer FP; Cintulova D; Pittrich DA; Wimmer L; Luethi D; Holy M; Jaentsch K; Tischberger S; Gmeiner G; Hoener MC; Liechti ME; Mihovilovic MD; Sitte HH
Neuropharmacology; 2019 Apr; 148():199-209. PubMed ID: 30610839
[TBL] [Abstract][Full Text] [Related]
12. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Loland CJ; Mereu M; Okunola OM; Cao J; Prisinzano TE; Mazier S; Kopajtic T; Shi L; Katz JL; Tanda G; Newman AH
Biol Psychiatry; 2012 Sep; 72(5):405-13. PubMed ID: 22537794
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
Davids E; Zhang K; Tarazi FI; Baldessarini RJ
Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
[TBL] [Abstract][Full Text] [Related]
14. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
Markowitz JS; Patrick KS
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678
[TBL] [Abstract][Full Text] [Related]
15. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
Jacquot C; David DJ; Gardier AM; Sánchez C
Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
[TBL] [Abstract][Full Text] [Related]
16. Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists.
Bøgesø KP; Liljefors T; Arnt J; Hyttel J; Pedersen H
J Med Chem; 1991 Jul; 34(7):2023-30. PubMed ID: 1676758
[TBL] [Abstract][Full Text] [Related]
17. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the active antifungal enantiomer, SCH 42427 (RR), and evaluation of its chiral inversion in animals following its oral administration and the oral administration of its racemate genaconazole (RR/SS).
Kim H; Radwanski E; Lovey R; Lin CC; Nomeir AA
Chirality; 2002 May; 14(5):436-41. PubMed ID: 11984759
[TBL] [Abstract][Full Text] [Related]
19. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
20. Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain.
Svendsen CN; Froimowitz M; Hrbek C; Campbell A; Kula N; Baldessarini RJ; Cohen BM; Babb S; Teicher MH; Bird ED
Neuropharmacology; 1988 Nov; 27(11):1117-24. PubMed ID: 2849726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
